Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The trigeminal parasympathetic pathway is a neuroanatomical route by which parasympathetic fibers reach target organs in the head and neck, using branches of the trigeminal nerve as conduits. This pathway regulates secretory functions such as tear and mucus production, and contributes to vascular regulation. Dysfunction or modulation is implicated in conditions like dry eye disease, and it's targeted by nasal neurostimulation devices. Key structures include the pterygopalatine ganglion and neurotransmitters like acetylcholine and CGRP.
Nasal neurostimulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trigeminal Parasympathetic Pathway.